logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutCareersContact UsSecurity
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Coupon and Savings
    3. Apellis Patient Assistance Program: Empaveli

    Apellis Patient Assistance Program: Empaveli

    Funded
    About
    The Apellis Patient Assistance Program: Empaveli offers significant support to patients in need, providing access to the drug Empaveli at no cost for eligible individuals. This program is invaluable for uninsured or underinsured patients diagnosed with paroxysmal nocturnal hemoglobinuria (PNH) who are enrolled in the ApellisAssist program. By emphasizing accessibility and affordability, the Apellis Patient Assistance Program: Empaveli ensures that financial challenges do not hinder necessary treatment.
    Insurance requirements: Underinsured, Uninsured
    Enrollment Forms
    Enrollment Form
    Program Requirements
    •Valid only for residents in the US and Puerto Rico
    •Enrollment Required: Yes
    •Coverage Required: No
    •Needs Based: Yes
    •Activation Required: No
    Program Details
    •The Apellis Patient Assistance Program may be able to help uninsured or underinsured patients obtain EMPAVELI at no cost
    •Patient must be enrolled in the ApellisAssist Pogram
    •Must have a valid prescription
    •Patients can enroll by phone (18666927527) or fax form to (18887541285)
    •For more information patients must call 18666927527 from 8 am 8 pm ET, MondayFriday or visit EMPAVELI.com
    Enrollment Forms
    Enrollment Form